Cera, a UK-based in-home healthcare provider, has raised $150 million in a combination of debt and equity to scale its AI-driven platform and expand its services. Led by BDT & MSD Partners and Schroders Capital, this funding will enhance Cera’s proprietary technology, which uses AI modeling and data analysis to predict patient risks including falls and hospitalizations. The company claims its system has reduced hospitalizations by up to 70 percent and patient falls by 20 percent. With 10,000 caregivers and nurses serving approximately 30 million people, Cera collaborates with more than 150 local governments and two-thirds of NHS Integrated Care Systems, playing a significant role in relieving pressure on the NHS by facilitating faster discharges and reducing the need for hospital care.
The new funding reflects confidence in Cera’s technology-driven approach, which has made it one of Europe’s largest home healthcare data collectors. The company has raised more than $407 million to date and has become EBITA-positive in 2023, achieving free cash flow positivity in 2024. CEO Ben Maruthappu emphasized that Cera’s platform provides comprehensive home-based care services, including nursing, physiotherapy, and mental health support. An independent analysis estimates that Cera’s AI-powered model saves the UK healthcare system $1.2 million daily, showcasing its growing impact and efficiency.
